News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Lalwani Nikhil
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/15/2023 |
4
| Lalwani Nikhil (PRESIDENT & CEO) has filed a Form 4 on ANI PHARMACEUTICALS INC|
Txns:
| Sold 56,666 shares
@ $57.75, valued at
$3.3M
Sold 11,616 shares
@ $61.13, valued at
$710.1k
Exercised 11,616 options to buy
@ $29, valued at
$336.9k
|
|
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/04/2023 |
4
| Lalwani Nikhil (PRESIDENT & CEO) has filed a Form 4 on ANI PHARMACEUTICALS INC|
Txns:
| Granted 95,530 shares
@ $0
Granted 63,686 shares
@ $0 |
|
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2023 |
4
| Lalwani Nikhil (PRESIDENT & CEO) has filed a Form 4 on ANI PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 9,397 shares
@ $44.23, valued at
$415.6k
Paid exercise price by delivering 4,265 shares
@ $44.23, valued at
$188.6k
|
|
| 09/12/2022 |
4
| Lalwani Nikhil (PRESIDENT & CEO) has filed a Form 4 on ANI PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 3,646 shares
@ $37.61, valued at
$137.1k
|
|
| 04/29/2022 |
4
| Lalwani Nikhil (PRESIDENT & CEO) has filed a Form 4 on ANI PHARMACEUTICALS INC|
Txns:
| Granted 33,352 shares
@ $0 |
|
| 03/28/2022 |
4
| Lalwani Nikhil (PRESIDENT & CEO) has filed a Form 4 on ANI PHARMACEUTICALS INC|
Txns:
| Granted 100,055 shares
@ $0 |
|
| 03/25/2022 |
4
| Lalwani Nikhil (PRESIDENT & CEO) has filed a Form 4 on ANI PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 17,454 shares
@ $27.03, valued at
$471.8k
|
|
| 03/23/2022 |
4
| Lalwani Nikhil (PRESIDENT & CEO) has filed a Form 4 on ANI PHARMACEUTICALS INC|
Txns:
| Bought 7,224 shares
@ $27.6851, valued at
$200k
|
|
| 09/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2020 |
4
| Lalwani Nikhil (PRESIDENT & CEO) has filed a Form 4 on ANI PHARMACEUTICALS INC|
Txns:
| Granted 28,508 shares
@ $0
Granted 179,643 options to buy
@ $29, valued at
$5.2M
|
|
| 09/10/2020 |
3
| Lalwani Nikhil (PRESIDENT & CEO) has filed a Form 3 on ANI PHARMACEUTICALS INC |
|
|